Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
K 41498 is a peptide antagonist of corticotropin-releasing factor receptor 2α (CRF2α) and CRF2β (Kis = 0.66 and 0.62 nM, respectively, in HEK293 cells expressing the human receptors).1 It is selective for CRF2α and CRF2β over CRF1 (Ki = 425 nM in HEK293 cells expressing the human receptor). K 41498 (1.84 µg/animal, i.v.) prevents hypotension induced by urocortin (Item No. 24745) in rats. Intrathecal administration of K 41498 (0.075-0.5 µmol/animal) decreases the mechanical paw withdrawal threshold in a rat model of nociception induced by complete Freund's adjuvant.2
WARNING This product is not for human or veterinary use.
1. The highly selective CRF2 receptor antagonist K41498 binds to presynaptic CRF2 receptors in rat brain. Br. J. Pharmacol. 136(6), 896-904 (2002).
2. Functional and anatomical characterization of corticotropin-